SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is seeing heightened community discussion as the stock breaks out of a multi-month accumulation phase and tests key resistance levels. Investors are actively debating the sustainability of this momentum, contrasting the company's growth in trading activity against persistent short seller activity and broader sector sentiment.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is trending as investors debate whether the stock's recent price consolidation represents a deep value opportunity ahead of earnings or a long-term decline in market share. The community is actively tracking potential institutional accumulation and short interest while speculating on the impact of Pepsi's distribution and the performance of newer product lines.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense investor activity and massive trading volume driven by significant interest from institutional and retail market participants regarding the company's autonomous defense technology and recent international contract wins. While bulls are highlighting the high short interest as a potential catalyst for a short squeeze and pointing to long-term defense pipeline growth, others remain cautious due to persistent downward price trends, concerns about share dilution, and the volatility inherent in the small-cap drone sector.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending as positive regulatory momentum surrounding the CLARITY Act and the rising price of Bitcoin drive a technical breakout on heavy volume. The community is actively debating whether this move signals a sustainable reversal or a bull trap, with many traders closely tracking the stock's performance against key resistance levels.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as high volume and unusual institutional activity fuel a technical breakout, with community members actively discussing a potential short squeeze and high-growth potential ahead of key clinical data readouts. Investors are particularly focused on the upcoming NSCLC pipeline updates, citing deep institutional accumulation and ongoing speculation about a potential strategic partnership or acquisition as key drivers for the current upward momentum.

T3 Defense, Inc. is a federated holding company focused on acquiring and operating mission-critical defense businesses embedded in long-cycle national security programs. The firm targets defense businesses operating at constrained, qualification-driven, or execution-critical points across the industrial base, where strategic value exists and where qualification, capacity, and execution are decisive. T3 Defense strengthens critical defense capabilities and compounds long-term value through disciplined M&A, centralized strategy and capital, and decentralized operations. The company was founded on May 24, 2019 and is headquartered in New York, NY.

T3 Defense Inc. - Ordinary Shares - New

T3 Defense is seeing extreme volatility as investors weigh the company's recent acquisition of a drone and counter-UAV technology firm against ongoing concerns regarding dilution and a pending reverse stock split. The community remains deeply divided, with some traders targeting a potential squeeze driven by the company's low market cap and defense-sector contracts, while others dismiss the stock as a dilution-heavy trap.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicor Corp. is trending as investors react to positive second-quarter earnings that significantly beat consensus estimates and showed strong growth in product revenues. The community is actively debating the stock's future, balancing enthusiasm over the company's role in the AI infrastructure power stack against concerns regarding volatility, valuation levels, and CEO insider selling.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending as investors react to a significant leadership shakeup following the immediate resignation of its CEO and a pivot toward strengthening its medical advisory board. Community discussion is heavily divided between long-term holders optimistic about the HLP003 Phase 3 clinical data and vocal skeptics concerned about historical share dilution and persistent executive turnover.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

Abeona Therapeutics is currently trending as investors focus on the commercial ramp-up of ZEVASKYN, highlighted by the recent activation of a fifth treatment center and robust demand from an identified pool of eligible patients. Community discourse remains centered on the company's path to profitability and potential for a short squeeze, with bullish sentiment bolstered by high institutional ownership and the strategic expansion of their Qualified Treatment Center network.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grumman is trending as investors weigh strong defense spending tailwinds against concerns over future budget constraints and government scrutiny on share buybacks. The community is actively debating the company's long-term valuation and order backlog strength amid significant volatility in defense-sector sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adhera Therapeutics, Inc. is an emerging specialty biotech company, which is in the process of evaluating its focus including a return to drug discovery and development. The company was founded on September 23, 1983 and is headquartered in Baton Rouge, LA.

Adhera Therapeutics Inc

Neutral Sentiment

Too early to tell

Semiconductor stocks have been under significant selling pressure in recent weeks, leaving retail investors debating whether the worst is over or if more downside lies ahead. Cast your vote and let us know your reasoning in the comments.

Is the pullback in semiconductor stocks over? 
 
Explain your reasoning in the comments.

Feed

News

Sentiment

Fundamentals

Info

ATRXAdhera Therapeutics Inc

Fundamentals

Latest ATRX News